Mutational Analysis of Human BLyS in Patients with Common Variable Immunodeficiency

  • Claretta Gioia Losi
  • Ulrich Salzer
  • Roberta Gatta
  • Vassilios Lougaris
  • Gemma Cattaneo
  • Antonella Meini
  • Annarosa Soresina
  • Bodo Grimbacher
  • Alessandro Plebani
Article

BLyS, a TNF family member, is crucial for B cell proliferation and differentiation by acting through its three receptors, TACI, BCMA and BAFF-R. The knock out model for BLyS is characterized by an immunological phenotype reminiscent of the human phenotype of common variable immunodeficiency (CVID). CVID is characterized by a defective B cell compartment, evidencing the putative importance of BLyS in its pathogenesis. On the contrary, the transgenic model for BLys is characterized by autoimmune manifestations, underlying its role in B cell regulation. In fact, mutations in TACI, one of the three BLyS receptors, are associated with CVID. Based on these facts, we hypothesized that BLyS could be a candidate gene for CVID. We screened 78 patients with CVID using DHPLC and direct sequencing: No disease causing mutations were identified. A novel heterozygous single nucleotide polymorphism (SNP) was found in exon 1 of one individual, however this SNP (G189A) does not lead to an amino acid substitution.

KEY WORDS:

TNF family BAFF BLyS B cell differentiation CVID Polymorphic variants Mutational analysis DHPLC 

Notes

AKNOWLEDGMENTS

We would like to thank the referring physicians for their collaboration, Mrs. Jessica Pfannstiel and Mrs. Giovanna Falsetti for excellent technical assistance. This work was partly supported by the Center for Primary Immunodeficiencies “Mario Di Martino” and Camillo Golgi Foundation, Brescia. B.G. and U.S. were supported by grants of the Deutsche Forschungsgemeinschaft (DFG) GR1617/3 and SFB620/C2, and a USIDnet grant NO1-A1-30070. Both groups were supported by EU Contract No. SP23-CT-2005-006411, EURO-POLICY-PID.

REFERENCES

  1. 1.
    Spickett GP: Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy 31(4):536–542, 2001 ReviewPubMedCrossRefGoogle Scholar
  2. 2.
    Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 92(1):34–48, 1999PubMedCrossRefGoogle Scholar
  3. 3.
    Goldacker S, Warnatz K: Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 5(6):504–509, 2005 ReviewPubMedCrossRefGoogle Scholar
  4. 4.
    Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, Eibel H, Schlesier M, Peter HH: Severe deficiency of switched memory B cells (CD27(+)IgM(−)IgD(−)) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease. Blood 99(5):1544–1551, 2002PubMedCrossRefGoogle Scholar
  5. 5.
    Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R, Eibel H, Fischer B, Schäffer A, Mages HW, Kroczek RA, Peter HH: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4:261–268, 2003PubMedCrossRefGoogle Scholar
  6. 6.
    Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Peter MHH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37:820–828, 2005PubMedCrossRefGoogle Scholar
  7. 7.
    Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37:829–834, 2005PubMedCrossRefGoogle Scholar
  8. 8.
    Shu HB, Hu WH, Johnson H: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65(5):680–683, 1999PubMedGoogle Scholar
  9. 9.
    Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB: Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem 274(23):15978–15981, 1999PubMedCrossRefGoogle Scholar
  10. 10.
    Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189(11):1747–1756, 1999PubMedCrossRefGoogle Scholar
  11. 11.
    Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM: BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285(5425):260–263, 1999PubMedCrossRefGoogle Scholar
  12. 12.
    Tribouley C, Wallroth M, Chan V, Paliard X, Fang E, Lamson G, Pot D, Escobedo J, Williams LT: Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 380(12):1443–1447, 1999PubMedCrossRefGoogle Scholar
  13. 13.
    Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillens S, Waggie K, Schrechhise RV, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH: TACI-Ig neutralized molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 15:289–302, 2001PubMedCrossRefGoogle Scholar
  14. 14.
    Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles D, Frew E, Scott ML: An essential role for BAFF in the normal development of B cells trough a BCMA-independent pathway. Science 293:2111–2114, 2001PubMedCrossRefGoogle Scholar
  15. 15.
    Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190(11):1697–1710, 1999PubMedCrossRefGoogle Scholar
  16. 16.
    Stewart DM, McAvory MJ, Hilbert DM, Nelson DL: B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clin Immunol 109(2):137–143, 2003PubMedCrossRefGoogle Scholar
  17. 17.
    Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K: analysis on the association of human BLyS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 3(7):424–429, 2002PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Claretta Gioia Losi
    • 1
    • 3
  • Ulrich Salzer
    • 2
  • Roberta Gatta
    • 1
  • Vassilios Lougaris
    • 1
  • Gemma Cattaneo
    • 1
  • Antonella Meini
    • 1
  • Annarosa Soresina
    • 1
  • Bodo Grimbacher
    • 2
  • Alessandro Plebani
    • 1
  1. 1.Istituto di Medicina Molecolare “Angelo Nocivelli,”Clinica Pediatrica, Università di BresciaBresciaItaly
  2. 2.Division of Rheumatology and Clinical ImmunologyMedical School, University of FreiburgFreiburgGermany
  3. 3.Istituto di Medicina Molecolare “Angelo Nocivelli,”Clinica Pediatrica, Università di BresciaBresciaItaly

Personalised recommendations